Clinical Trials Browser

Completed × OTHER × ivosidenib × Clear all

NCT03564821 2025-11-04

IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation

Phase 1 Completed

IDH1 Mutation Myeloid Neoplasms

NCT04056910 2025-02-27

Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors

Phase 2 Completed

15 enrolled 14 charts

Glioma